Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||0.00%||8.00||0.7%||$559.23m|
|GILD||Gilead Sciences, Inc.||-0.37%||64.65||1.0%||$470.67m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.51%||479.47||2.7%||$433.31m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.07%||216.10||1.9%||$372.34m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.00%||153.73||2.0%||$315.33m|
|EXAS||EXACT Sciences Corp.||1.52%||129.95||18.4%||$197.83m|
|NBIX||Neurocrine Biosciences, Inc.||3.26%||96.00||4.9%||$178.12m|
|CRSP||CRISPR Therapeutics AG||1.13%||122.25||0.6%||$171.27m|
|TXG||10X Genomics, Inc.||0.00%||197.36||0.0%||$149.02m|
Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.